New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 14, 2013
09:33 EDTCBM, DOWCambrex, Dow Chemical collaborate to manufacture drug-solubility solution
Cambrex (CBM) and Dow Chemical (DOW) have executed an agreement for Cambrex to contract manufacture Dow Hydroxypropyl Methylcellulose Acetate Succinate, or HPMCAS, for Drug Solubility Enhancement. Construction has already begun on the new operational facility at Cambrex Karlskoga with commercial product availability set for year-end 2013.
News For CBM;DOW From The Last 14 Days
Check below for free stories on CBM;DOW the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 8, 2014
07:24 EDTDOWPR News to hold a conference
Subscribe for More Information
April 3, 2014
07:04 EDTDOWDow Chemical price target raised to $57 from $52 at UBS
UBS believes Dow Chemical's earnings are bottoming and that oil-based chemicals are near trough. The firm shifted its price target to 2015 estimates and raised it to $57 from $52 and maintains its Buy rating.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use